These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7705550)
1. Regulation of pancreatic polypeptide release is mediated through M3 muscarinic receptors. Tanikawa M; Hayakawa T; Kondo T; Naruse S; Shibata T; Kitagawa M Digestion; 1994; 55(6):374-9. PubMed ID: 7705550 [TBL] [Abstract][Full Text] [Related]
2. Subtypes of muscarinic receptors in pancreatic exocrine secretion in anesthetized dog. Iwatsuki K; Horiuchi A; Yonekura H; Homma N; Haruta K; Chiba S Pancreas; 1989; 4(3):339-45. PubMed ID: 2734277 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of the M1-receptor antagonist telenzepine and the CCK-receptor antagonist loxiglumide on the pancreatic secretory response to intraduodenal tryptophan in dogs. Teyssen S; Niebergall-Roth E; Rausch A; Beglinger C; Riepl RL; Chari S; Singer MV Pancreas; 1996 Nov; 13(4):407-16. PubMed ID: 8899802 [TBL] [Abstract][Full Text] [Related]
4. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs. Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032 [TBL] [Abstract][Full Text] [Related]
5. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man. Gabryelewicz A; Kulesza E; Konturek SJ Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088 [TBL] [Abstract][Full Text] [Related]
6. Cholinergic regulation of PP release is mediated through muscarinic M1-receptors. Kleibeuker JH; Jansen JB; Lamers CB Digestion; 1989; 43(1-2):60-5. PubMed ID: 2806756 [TBL] [Abstract][Full Text] [Related]
7. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs. Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223 [TBL] [Abstract][Full Text] [Related]
8. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712 [TBL] [Abstract][Full Text] [Related]
9. Intestinal phase of human antro-pyloro-duodenal motility: cholinergic and CCK-mediated regulation. Katschinski M; Schirra J; Begliner C; Langbein S; Wank U; D'Amato M; Arnold R Eur J Clin Invest; 1996 Jul; 26(7):574-83. PubMed ID: 8864420 [TBL] [Abstract][Full Text] [Related]
10. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog. Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149 [TBL] [Abstract][Full Text] [Related]
11. Subtypes of muscarinic receptors in canine pancreatic secretion in vivo and in vitro. Konturek SJ; Jaworek J; Tasler J; Cieszkowski M; Yanaihara N Int J Pancreatol; 1987 Feb; 2(1):11-22. PubMed ID: 2445873 [TBL] [Abstract][Full Text] [Related]
12. Muscarinic M3 receptor-mediated release of gastrin from canine antral G cells in primary culture. Yokotani K; DelValle J; Park J; Yamada T Digestion; 1995; 56(1):31-4. PubMed ID: 7895929 [TBL] [Abstract][Full Text] [Related]
13. Effect of divalent cations on gastrointestinal hormone release and exocrine pancreatic secretion in dogs. Inoue K; Fried GM; Wiener I; Sakamoto T; Lilja P; Greeley GH; Watson LC; Thompson JC Am J Physiol; 1985 Jan; 248(1 Pt 1):G28-34. PubMed ID: 3966559 [TBL] [Abstract][Full Text] [Related]
14. The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog. Meyer FD; Gyr K; Häcki WH; Beglinger C; Jeker L; Varga L; Kayasseh L; Gillessen D; Stalder GA Gastroenterology; 1981 Apr; 80(4):742-7. PubMed ID: 7202946 [TBL] [Abstract][Full Text] [Related]
16. Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs. Kim CK; Lee KY; Wang T; Sun G; Chang TM; Chey WY Am J Physiol; 1989 Dec; 257(6 Pt 1):G944-9. PubMed ID: 2481981 [TBL] [Abstract][Full Text] [Related]
17. M1 muscarinic mechanisms regulate intestinal-phase gallbladder physiology in humans. Nelson DK; Glasbrenner B; Dahmen G; Riepl RL; Malfertheiner P; Adler G Am J Physiol; 1996 Nov; 271(5 Pt 1):G824-30. PubMed ID: 8944697 [TBL] [Abstract][Full Text] [Related]
18. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs. Hosotani R; Chowdhury P; Huang YS; McKay D; Yajima H; Rayford PL Pancreas; 1989; 4(5):550-5. PubMed ID: 2813326 [TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal motor and secretory responses to cholinergic stimulation in humans. Differential modulation by muscarinic and cholecystokinin receptor blockade. Katschinski M; Steinicke C; Reinshagen M; Dahmen G; Beglinger C; Arnold R; Adler G Eur J Clin Invest; 1995 Feb; 25(2):113-22. PubMed ID: 7737260 [TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin is a regulator of intestinal phase-stimulated PP release. Adler G; Beglinger C; Braun U; Reinshagen M; Koop I; Schafmayer A Regul Pept; 1990 Sep; 30(2):105-11. PubMed ID: 2274676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]